17.06.2015 • NewsDede Willamscancerbreast

Prenatal DDT Exposure Linked To Breast Cancer

© 18percentgrey - Fotolia.com
© 18percentgrey - Fotolia.com

Women exposed to higher levels of the pesticide DDT while in utero face increased risk of breast cancer later in life than those exposed to lower levels, according to new research published in the US Journal of Clinical Endocrinology & Metabolism.

Researchers evaluated 54 years of data from women, including 9,300 tracked from even before birth. Of the number, the study’s authors identified 118 women who had been diagnosed with breast cancer. Those whose mothers had been exposed to significant levels of DDT in pregnancy were found four times more likely to contract breast cancer than those  exposed to a small quantity.

Study author Dr. Barbara Cohn, a researcher at the Public Health Institute in Berkeley, California, said the research found “direct evidence” that higher DDT exposure in utero places women at increased risk of breast cancer.

“Environmental chemicals have long been suspected causes of breast cancer, but until now, there have been few human studies to support this idea,” Cohn said.

DDT, one of the first known endocrine disruptors, has been banned in most Western countries since the 1970s. Still, the study’s authors point out that many potentially affected women born in that era are just reaching the age when they are at increased risk for breast cancer.

Despite this and other health risks linked to DDT, including Alzheimer’s disease, obesity, and kidney and ovarian diseases, some countries still use the chemical to fight malaria, the study points out.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.